[go: up one dir, main page]

AR056154A1 - PREPARATION PROCEDURE FOR 8-FLUORO-NAFTALEN-1-ILAMINE AND THE USE OF THIS IN OBTAINING A SYNTHESIS INTERMEDIARY 7- {4- [4- (8-FLUORO-NAFTALEN-1-IL) -PIPERAZIN-1 -IL] -BUTOXI} -3, 4-DIHIDRO-1H- [1, 8] NAFTIRIDIN-2-ONA - Google Patents

PREPARATION PROCEDURE FOR 8-FLUORO-NAFTALEN-1-ILAMINE AND THE USE OF THIS IN OBTAINING A SYNTHESIS INTERMEDIARY 7- {4- [4- (8-FLUORO-NAFTALEN-1-IL) -PIPERAZIN-1 -IL] -BUTOXI} -3, 4-DIHIDRO-1H- [1, 8] NAFTIRIDIN-2-ONA

Info

Publication number
AR056154A1
AR056154A1 ARP060104638A AR056154A1 AR 056154 A1 AR056154 A1 AR 056154A1 AR P060104638 A ARP060104638 A AR P060104638A AR 056154 A1 AR056154 A1 AR 056154A1
Authority
AR
Argentina
Prior art keywords
fluoro
naftalen
ona
piperazin
naftiridin
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR056154A1 publication Critical patent/AR056154A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/64—Preparation of compounds containing amino groups bound to a carbon skeleton by disproportionation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Se describe un procedimiento para la preparacion de 8-fluoro-naftalen-1-ilamina que comprende hacer reaccionar 1H-nafto[1,8-de][1,2,3]triazina con fluoruro de hidrogeno o un complejo de fluoruro de hidrogeno y una base n-donadora. Se indica también un procedimiento para uso de 8-fluoro-naftalen-1-ilamina producido como se describio anteriormente en la preparacion de 1-(8-fluoro-naftalen-1-il)-piperazina, que se puede usar como un intermediario en la produccion de 7-{4-[4-(8-fluoro-naftalen-1- il)-piperazin.-1-il]-butoxi}-3,4-dihidro-1H-[1,8]naftiridin-2-ona, un agonista parcial de D2 indicado para posible uso en el tratamiento de esquizofrenia.A process for the preparation of 8-fluoro-naphthalen-1-ylamine is described which comprises reacting 1H-naphtho [1,8-de] [1,2,3] triazine with hydrogen fluoride or a hydrogen fluoride complex and an n-donor base. A procedure for use of 8-fluoro-naphthalen-1-ylamine produced as described above in the preparation of 1- (8-fluoro-naphthalen-1-yl) -piperazine, which can be used as an intermediate in the production of 7- {4- [4- (8-fluoro-naphthalen-1- yl) -piperazin.-1-yl] -butoxy} -3,4-dihydro-1H- [1,8] naphthyridin-2 -ona, a partial D2 agonist indicated for possible use in the treatment of schizophrenia.

ARP060104638 2005-10-24 2006-10-24 PREPARATION PROCEDURE FOR 8-FLUORO-NAFTALEN-1-ILAMINE AND THE USE OF THIS IN OBTAINING A SYNTHESIS INTERMEDIARY 7- {4- [4- (8-FLUORO-NAFTALEN-1-IL) -PIPERAZIN-1 -IL] -BUTOXI} -3, 4-DIHIDRO-1H- [1, 8] NAFTIRIDIN-2-ONA AR056154A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72953005P 2005-10-24 2005-10-24

Publications (1)

Publication Number Publication Date
AR056154A1 true AR056154A1 (en) 2007-09-19

Family

ID=37885854

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104638 AR056154A1 (en) 2005-10-24 2006-10-24 PREPARATION PROCEDURE FOR 8-FLUORO-NAFTALEN-1-ILAMINE AND THE USE OF THIS IN OBTAINING A SYNTHESIS INTERMEDIARY 7- {4- [4- (8-FLUORO-NAFTALEN-1-IL) -PIPERAZIN-1 -IL] -BUTOXI} -3, 4-DIHIDRO-1H- [1, 8] NAFTIRIDIN-2-ONA

Country Status (4)

Country Link
JP (1) JP2007119461A (en)
AR (1) AR056154A1 (en)
TW (1) TW200800890A (en)
WO (1) WO2007049124A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023007515A (en) * 2019-12-10 2023-01-19 国立大学法人京都大学 Luminescent material, organic luminescent element and compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE147852C (en) *

Also Published As

Publication number Publication date
JP2007119461A (en) 2007-05-17
WO2007049124A1 (en) 2007-05-03
TW200800890A (en) 2008-01-01

Similar Documents

Publication Publication Date Title
TNSN08460A1 (en) 1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
MY150448A (en) 1- [2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition
MY157871A (en) Mapk/erk kinase inhibitors
BRPI0514125A (en) condensed pyridines as kinase inhibitors
TW200800970A (en) Novel cycloalkane carboxamides
AR052404A1 (en) 4 - ((((7R) -8-CYCLOPENTIL-7-ETIL-5,6,7,8-TETRAHYDRO-5-METHYL-6-OXO-2-PTERIDINYL) AMINO) -3- METOXI-N - (1-METHYL-4-PIPERIDINYL) -BENZAMIDE, PROCEDURE FOR PREPARATION AND USE AS A PHARMACO
MEP53708A (en) 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl) -n-methyl -amino) -anilino)-1- phenyl-methylene] -6-methoxycarbonyl -2-indolinone -monoethanesulphonate and the use thereof as a pharmaceutical composition
ES2195785B1 (en) NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA.
ECSP056071A (en) NEW DIFENILAZETIDINONA WITH IMPROVED PHYSIOLOGICAL FEATURES, CORRESPONDING PRODUCTION METHOD, MEDICATIONS CONTAINING SUCH COMPOUND AND ITS USE
CY1105994T1 (en) ARRANGEMENT PENTANOLS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY AGENTS
BR0312882A (en) Pleuromutilin derivatives as antimicrobials
MX2009005813A (en) Method for producing betamimetics.
DE602004022352D1 (en) Use of 1- (2-ethylhexyl) glycerin for the disinfection of surfaces above room temperature
MA32818B1 (en) Arylpiperazine and their use as alpha 2c antagonists
DE602006021539D1 (en) Morpholine als 5ht2c-agonisten
ATE345326T1 (en) N-BENZOYLUREIDO CINNAMON UREDERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
GEP20105071B (en) Processes for preparing 4-(phenoxy-5-methyl-pyrimidin-4-yloxy) piperidine-1-carboxylic acid derivatives and related compounds
MXPA06013387A (en) Novel pyridazinone derivatives as inhibitors of cdk2.
UY26656A1 (en) "METABOLITES AGONISTS / ANTAGONISTS OF ESTROGEN"
DE60141129D1 (en) HIGH-PRESSURE FAMILY AND OPTICAL WINDOW
AR056154A1 (en) PREPARATION PROCEDURE FOR 8-FLUORO-NAFTALEN-1-ILAMINE AND THE USE OF THIS IN OBTAINING A SYNTHESIS INTERMEDIARY 7- {4- [4- (8-FLUORO-NAFTALEN-1-IL) -PIPERAZIN-1 -IL] -BUTOXI} -3, 4-DIHIDRO-1H- [1, 8] NAFTIRIDIN-2-ONA
DE602004007533D1 (en) PROCESS FOR PRODUCING ACTIVATED CARBON FOR AN ELECTRODE OF AN ELECTRIC DOUBLE-LAYER CONDENSER
MY148242A (en) Process for making trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
AU309081S (en) Holder for a scrubber
MXPA06000038A (en) 2-substituted pyrimidines.

Legal Events

Date Code Title Description
FB Suspension of granting procedure